A 19-year-old college student from Wisconsin died from an allergic reaction caused by peanuts. According to local ABC News ...

Are you one of these people who loathes spending time outdoors at dusk as the weather warms and mosquitoes start biting?

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore ...

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

Allergens like mold, pollen, and dust, if you’re sensitive to them, can inflame the throat and affect mucus production.

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

As pet owners, we always want the best for our furry companions. While we often focus on their health, diet, and daily ...

Today there are more options than ever for managing migraine effectively. Find out what might work for you with this comprehensive guide to acute and preventive prescription drugs.

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...